These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21777352)

  • 1. Early subclinical cochlear dysfunction in myotonic dystrophy type 1.
    Pisani V; Tirabasso A; Mazzone S; Terracciano C; Botta A; Novelli G; Bernardi G; Massa R; Di Girolamo S
    Eur J Neurol; 2011 Dec; 18(12):1412-6. PubMed ID: 21777352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study.
    Bolay H; Bayazit YA; Gündüz B; Ugur AK; Akçali D; Altunyay S; Ilica S; Babacan A
    Cephalalgia; 2008 Apr; 28(4):309-17. PubMed ID: 18279433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inner ear dysfunction in myotonic dystrophy type 1.
    Balatsouras DG; Felekis D; Panas M; Xenellis J; Koutsis G; Kladi A; Korres SG
    Acta Neurol Scand; 2013 May; 127(5):337-43. PubMed ID: 23121018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of cochlear active mechanisms in tinnitus subjects with normal hearing sensitivity: multiparametric recording of evoked otoacoustic emissions and contralateral suppression.
    Paglialonga A; Del Bo L; Ravazzani P; Tognola G
    Auris Nasus Larynx; 2010 Jun; 37(3):291-8. PubMed ID: 19879078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cochlear active mechanisms in young normal-hearing subjects affected by Williams syndrome: time-frequency analysis of otoacoustic emissions.
    Paglialonga A; Barozzi S; Brambilla D; Soi D; Cesarani A; Gagliardi C; Comiotto E; Spreafico E; Tognola G
    Hear Res; 2011 Feb; 272(1-2):157-67. PubMed ID: 20969939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inner ear involvement in Behçet's disease.
    Süslü AE; Polat M; Köybaşi S; Biçer YO; Funda YO; Parlak AH
    Auris Nasus Larynx; 2010 Jun; 37(3):286-90. PubMed ID: 19864091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related declines in distortion product otoacoustic emissions utilizing pure tone contralateral stimulation in CBA/CaJ mice.
    Varghese GI; Zhu X; Frisina RD
    Hear Res; 2005 Nov; 209(1-2):60-7. PubMed ID: 16061336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory abnormalities, including 'precocious presbyacusis', in myotonic dystrophy.
    Huygen PL; Verhagen WI; Noten JF
    Audiology; 1994; 33(2):73-84. PubMed ID: 8179517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between auditory threshold and transitory evoked otoacoustic emissions].
    Komazec Z; Milosević D; Mocko M; Dankuc D; Vlaski L
    Srp Arh Celok Lek; 2002; 130 Suppl 1():8-11. PubMed ID: 12395455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of distortion products of otoacoustic emissions in presbycusis].
    Nieschalk M; Hustert B
    Laryngorhinootologie; 1996 Mar; 75(3):129-34. PubMed ID: 8652027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DPOAE in tinnitus patients with cochlear hearing loss considering hyperacusis and misophonia].
    Sztuka A; Pośpiech L; Gawron W; Dudek K
    Otolaryngol Pol; 2006; 60(5):765-72. PubMed ID: 17263252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measuring and analyzing of otoacoustic emission tests of a family with genetic progressive sensorineural hearing loss].
    Yu H; Ke XM; Yu DL; Li Q; Liu YH; Ding GY
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 14(4):157-9. PubMed ID: 12541488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distortion product otoacoustic emission findings in Behçet's disease and rheumatoid arthritis.
    Bayazit YA; Yilmaz M; Gunduz B; Altinyay S; Kemaloglu YK; Onder M; Gurer MA
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):233-8. PubMed ID: 17409782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochlear function in facioscapulohumeral muscular dystrophy.
    Balatsouras DG; Korres S; Manta P; Panousopoulou A; Vassilopoulos D
    Otol Neurotol; 2007 Jan; 28(1):7-10. PubMed ID: 17106430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in transient-evoked otoacoustic emission levels with negative tympanometric peak pressure in infants and toddlers.
    Prieve BA; Calandruccio L; Fitzgerald T; Mazevski A; Georgantas LM
    Ear Hear; 2008 Aug; 29(4):533-42. PubMed ID: 18469719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
    Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transiently evoked otoacoustic emissions in patients with cerebellopontine angle tumors.
    Cane MA; Lutman ME; O'Donoghue GM
    Am J Otol; 1994 Mar; 15(2):207-16. PubMed ID: 8172303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of methods for early detection of noise vulnerability of the inner ear. Amplitude reduction of otoacoustic emissions are most sensitive at submaximal noise impulse exposure].
    Plinkert PK; Hemmert W; Zenner HP
    HNO; 1995 Feb; 43(2):89-97. PubMed ID: 7713771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochlear origin of hearing loss in MELAS syndrome.
    Sue CM; Lipsett LJ; Crimmins DS; Tsang CS; Boyages SC; Presgrave CM; Gibson WP; Byrne E; Morris JG
    Ann Neurol; 1998 Mar; 43(3):350-9. PubMed ID: 9506552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of cochlear manifestations of presbycusis by acoustic oto-emissions. Review of the literature].
    Bonfils P; Cymes M; Uziel A; Ores S
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(1):63-5. PubMed ID: 2491717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.